
The introduction of a meningitis B booster vaccine for teenagers in Galicia could mark a turning point for Spain’s entire healthcare system. The decision comes amid alarming reports of outbreaks in Europe and fatalities among young people, highlighting the seriousness of the issue for Spanish families. This new measure promises to increase protection for teenagers who have not previously been systematically immunized against this dangerous disease.
According to 20minutos, in recent months both the UK and Spain have reported deaths among teenagers caused by meningococcal infection. In particular, an outbreak at the University of Kent in England resulted in the deaths of two young people, while in Spain, a 17-year-old girl from Alicante and a 15-year-old from Badajoz died within a single week. Experts warn that such outbreaks could occur in any country if vaccination rates among young people remain low.
Galicia’s response
Galician President Alfonso Rueda has announced the inclusion of a meningitis B booster dose for 12-year-old teenagers. Those who completed a full vaccination course as infants will need only one dose, while others will require two. Galicia becomes the first autonomous community to implement this practice, even though the national Ministry of Health has yet to support such a strategy.
The Asociación Española contra la Meningitis and leading pediatricians have supported the initiative, emphasizing that teenagers are the second most vulnerable group after children under 4. In their view, expanding vaccination among young people will help prevent severe outcomes and reduce the risk of new outbreaks.
Statistics and risks
According to the National Center for Epidemiology, in 2025 Spain confirmed 349 cases of invasive meningococcal infection, 22 of which were fatal. By March 2026, 75 cases and 9 deaths had already been recorded. Serogroup B remains the most common across all age groups. The disease’s mortality rate ranges from 6.5% to 13% in different years, making it one of the most dangerous airborne infections.
Pediatricians point out that meningitis B often spreads through close contact—at parties, nightclubs, and shared housing. People aged 14–25 are more likely to carry the bacteria due to their lifestyle and social activity. According to experts, the outbreak in Kent could have been prevented if teenagers had been vaccinated.
Position of the Ministry of Health and experts
Spain’s Ministry of Health has not yet included the booster dose of the meningitis B vaccine for teenagers in the national schedule, citing the low overall incidence and the limited collective impact of the vaccine. The agency prefers targeted vaccination in case of outbreaks and prioritizes protection for high-risk groups. However, the Association of Pediatricians, starting from 2025, recommends broader protection for teenagers, taking into account the rising number of cases and the unpredictability of the epidemiological situation.
Doctors emphasize that vaccinating teenagers not only reduces the risk of severe illness but also limits the likelihood of the infection spreading within the community. In Spain, the vaccine is available in pharmacies with a prescription but is not state-funded for this age group, which restricts coverage.
Context and consequences
Galicia already has experience dealing with major meningitis outbreaks: in the 1970s-80s, the region faced the largest epidemic in Western Europe. Today’s decision could set an example for other regions if the effectiveness of booster vaccination is confirmed. According to russpain.com, the introduction of new measures in Galicia may speed up the review of national recommendations and increase youth protection across the country.
Meningitis B is transmitted through close contact, kissing, sharing utensils, and prolonged time spent in enclosed spaces. Symptoms include high fever, headache, neck stiffness, sensitivity to light, as well as skin rashes and confusion. The disease progresses rapidly and can be fatal within 24 hours. Children under 5 and teenagers, especially those who are highly socially active, are most at risk.
In recent years, Europe has seen an increase in meningitis B outbreaks among young people, particularly in university campuses and crowded public places. In Spain, since 2022, vaccination against meningitis B has been mandatory for infants, but teenagers born before this remain less protected. The introduction of a booster dose in Galicia could mark the beginning of a new approach to tackling this disease.












